⌘K

Login Start Free

Home/Filings/4/0001127602-21-030063

4//SEC Filing

ASELAGE STEVE 4

Accession 0001127602-21-030063

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 4:15 PM ET

Size

4.4 KB

Accession

0001127602-21-030063

Insider Transaction Report

Form 4

Period: 2021-11-30

BIOCRYST PHARMACEUTICALS INCBCRX

Director

Transactions

Award
Common Stock
2021-11-30$12.06/sh+414$4,993→ 32,858 total

Footnotes (1)

[F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001221599

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 4:15 PM ET
Size: 4.4 KB

View on SEC.gov